Blood Journal Citation Rate 2026
0006-4971
eISSN 1528-0020
Elsevier BV
US
Q3 Quartile
About Blood
Blood (B) is a peer-reviewed academic journal covering Acute Myeloid Leukemia Research and Chronic Lymphocytic Leukemia Research, published by Elsevier BV in US, catalogued under ISSN 0006-4971 (e-ISSN 1528-0020). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 1.23 (Q3 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model.
Authors typically receive a first decision in around 87 days.
Blood Citation Rate 2026 — In Context
Blood has a 2025 2-Year Citation Rate (OpenAlex) of 1.23, placing it in the Q3 quartile within the Acute Myeloid Leukemia Research research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
Blood operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view. Average submission-to-decision turnaround is approximately 87 days.
Researchers looking to publish in Blood should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Blood against similar journals in the field, use our journal comparison tool.
Submission Tips for Blood
- Be prepared for a longer review cycle — decisions typically take around 87 days.
- This journal covers Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Blood Compares
Compared against 2 journals in the same research areas.
| ISSN (Print) | 0006-4971 |
|---|---|
| ISSN (Online) | 1528-0020 |
| Publisher | Elsevier BV |
| Country | United States |
| APC / Cost | Inquire with Publisher |
| Review Speed | ~87 days to first decision |
In-depth profile & metrics
Blood is published by Elsevier BV and based in United States.
In our subject taxonomy, Blood is classified under Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments and Hematopoietic Stem Cell Transplantation.
For prospective authors, Blood returns a first decision in about 87 days (longer for its field).
Its most recent citation rate stands at 1.231.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Blood
Live Indexing Status
Updated July 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 1.231 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Journal Metrics
Research Highlights
Recently published high-impact papers in this journal:
-
Imatinib and nilotinib are equally successful in achieving therapy-free remission
Fang Cheng, Yu Xin Wang, Yunfan Yang • 2026
Compare Journals
Compare Blood against similar publications in its field:
Related Journals in Your Field
-
Genes Chromosomes and Cancer Wiley IF 1.51
-
Pathology International Wiley IF 0.93
Explore More Journals
Metadata
Last updated: Jul 12, 2026
Updated by: system
Get weekly updates for Acute Myeloid Leukemia Research journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.